Politics of Medicines
Free Online Encycopedia
HAI
  • home
  • project
  • a-z articles
  • a-z index
  • a-z authors
  • contact
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Access to Essential Medicines
  • Access to Essential Medicines as a Human Right
  • Access with Evidence Development
  • ACTA from an Access to Medicines Point of View
  • Activism
  • Competition Policy
  • Complementary (Traditional & Herbal) Medicines: An Australian Regulatory Perspective
  • Defined Daily Doses
  • Dependence on Medicines: An Historical Perspective
  • Disease-mongering
  • Drug Utilisation
  • Drugs for Neglected Diseases initiative; Best Science for the Most Neglected
  • External Reference Pricing
  • Generics Competition in the EU, US and Canada
  • Health Action International (HAI)
  • Health Care Professionals
  • Independent Information About Medicines
  • Innovation: New Is Not Necessarily Better
  • International Aid and Access to Health Products
  • International Drug Price Indicator Guide
  • Learning How Not to Do the Pharmaceutical Industry Tango: Raising Student Awareness of Ethical Conflicts of Interest
  • Médecins Sans Frontières
  • Medicines and Therapeutics Committees and their Roles
  • Mission Sector
  • Models for Financing the Regulation of Pharmaceutical Promotion
  • National Medicines Policy
  • Neoliberal Policies in Healthcare
  • Patients' Organisations and Patient Empowerment
  • Pharmaceutical Promotion
  • Pharmaceutical R&D
  • Pharmaceutical Sales Representatives
  • Prescribing by International Non-proprietary Name
  • Private Health Insurance
  • Promotion of Medicines and Patient Health
  • Promotion to Consumers: Responding to Patient Requests for Advertised Medicines
  • Promotion, Professional Practice and Patient Trust
  • Quantification of Medicines Requirements
  • Regulation of Pharmaceutical Promotion: Why Does Regulation Matter?
  • Sales Taxes on Medicines
  • The Anatomical Therapeutic Chemical (ATC) Classification System
  • The Cochrane Collaboration
  • The International Network for Rational Use of Drugs (INRUD)
  • The Medicines Patent Pool
  • The Regulation of Mark-ups in the Pharmaceutical Supply Chain
  • The Role of Evidence-Based Medicine in Rational Drug Use
  • Traditional Medicine
  • Using Unbiased Prescribing Information
  • WHO Guide to Good Prescribing

recent articles

Access to Essential Medicines as a Human Right
June 11, 2016 – The Working Group on Access to Essential Medicines of the United Nations Millennium Project, adopting ...

ACTA from an Access to Medicines Point of View
January 8, 2013 – This year, there were fireworks on both sides of the Atlantic for the 4th of July when the European Parliament ...

Patients' Organisations and Patient Empowerment
December 5, 2012 – A news item posted on the European Medicines Agency’s website in September 2010 announced that its ...

  • print page

Copyright © 2011 - 2018 

HAI Global. All rights reserved. Overtoom 60-2, 1054 HK Amsterdam, The Netherlands, info@politicsofmedicines.org